Calvert Equation:
From: | To: |
The Calvert equation is used to calculate the appropriate dose of carboplatin chemotherapy based on the target area under the curve (AUC) and the patient's glomerular filtration rate (GFR). It provides personalized dosing for optimal efficacy and reduced toxicity.
The calculator uses the Calvert equation:
Where:
Explanation: The equation accounts for the relationship between drug clearance and renal function, with the constant 25 representing non-renal clearance of carboplatin.
Details: Accurate carboplatin dosing is crucial for maximizing therapeutic effect while minimizing toxicity, particularly myelosuppression. The Calvert equation allows for individualized dosing based on renal function.
Tips: Enter the target AUC value (typically between 4-7 mg/ml/min for most regimens) and the patient's GFR (measured or estimated). All values must be valid positive numbers.
Q1: What is the typical AUC range for carboplatin dosing?
A: Most regimens use AUC values between 4-7 mg/ml/min, though this varies based on cancer type, treatment intent, and combination therapy.
Q2: How should GFR be measured for this calculation?
A: The equation was originally validated with measured GFR (using radiolabeled EDTA), but estimated GFR using CKD-EPI or Cockcroft-Gault equations is commonly used in practice.
Q3: Are there limitations to the Calvert equation?
A: The equation may be less accurate in patients with extreme body weights, very low GFR, or those receiving hemodialysis.
Q4: Should dose be adjusted for obese patients?
A: Current guidelines recommend using actual body weight for GFR estimation and the Calvert equation without additional adjustments for obesity.
Q5: How often should dosing be recalculated?
A: Dosing should be recalculated for each cycle if there are significant changes in renal function or body weight.